Jon Magnus Tangen

Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial (2007)

Torfoss, Dag, Høiby, E. Arne, Tangen, Jon Magnus, Holte, Harald, Bø, Kåre, Meyer, Peter, ...

Objectives Penicillin G with an aminoglycoside is the standard initial empirical treatment in febrile neutropenia in Norway. It has been argued that giving the aminoglycoside once daily to...

Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial (2007)

Torfoss, Dag, Høiby, E. Arne, Tangen, Jon Magnus, Holte, Harald, Bø, Kåre, Meyer, Peter, ...

Objectives Penicillin G with an aminoglycoside is the standard initial empirical treatment in febrile neutropenia in Norway. It has been argued that giving the aminoglycoside once daily to...

Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group. (2006)

Lenhoff, Stig, Hjorth, Martin, Westin, Jan, Brinch, Lorentz, Backstrom, Bengt, Carlson, Kristina, ...

Abstract is not available

Kostnader ved høydosebehandling med autolog stam-cellestøtte ved fire norske sentra

Mishra, Vinod, Brinch, Lorentz, Ernst, Peter, Lønseth, May Kristin, Tangen, Jon Magnus, Wikelund, Jenny, ...

Høydosebehandling med autolog stamcellestøtte (HMAS) er rutinebehandling hos selekterte grupper av pasienter med malignt lymfom og myelomatose. Hva er kostnadene ved denne type behandling? I...